Complex polycystic ovary syndrome is a dubious disease in the areas of autoimmune and rheumatic immunity, clinical performance is complex and often involves multi-system fatigue. Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in linking teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of complex polycystic ovary syndrome requires individual development of treatment programs, usually including pharmacotherapy, rehabilitation interventions, regular follow-up, and more. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immunodeficiency disorders that were previously difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions and adapted to timely regimens according to changes in conditions. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of cardiovascular complications of relapsing multiple sclerosis. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.